Three quarters of a mile from civilization

Views, analysis & commentary - essentially on venture capital & pharmaceutical industry

Thursday, April 24, 2014

Being a CVC - A perspective on Novartis Venture Fund's investment (& exit) strategy

›
If anything, the recent news of Novartis agreeing to sell its vaccine & veterinary businesses while simultaneously acquiring oncology...
1 comment:
Friday, February 28, 2014

Not wanting to sell-off is key to being bought!

›
19 billion dollars for a company with one app & 20 million in revenue is of course a frickin’ big deal - No wonder that everyone fro...
Saturday, February 22, 2014

Isn't securing employee personal information equally important (vis-a-vis' company data) in a BYOD scenario?

›
The title of a recent article on W.I.R.E.D Innovation Insights asks " How Secure Is Your Company's Information With the Mobile-Ca...
Thursday, January 30, 2014

Is YODA-enabled clinical data-transparency more than smart externalization of clinical data-mining & analysis?

›
The day started with a news item on Xconomy declaring " J&JOpens Data Vault to Yale, in ‘Unprecedented’ Transparency Move" ...
Tuesday, January 21, 2014

Funds-on-Tap is passé & Drip-Funding is the new reality.

›
It’s probably been true for IT/ ITES ( particularly for e-commerce and social media & app-developers ) much longer, but for the drug...
Monday, January 6, 2014

Manna from the mud - Daliya!

›
No, I’m not transforming my venture-blog into a food-blog! Despite a rather underwhelming 2013, I am just not ready to give up chasing...
1 comment:
Saturday, December 21, 2013

A suitably bootstrapped perspective

›
As someone who routinely wears boots under Levi’s 511s, I understand the sheer utility of those small loops called bootstraps - Sramana Mi...
‹
›
Home
View web version
Powered by Blogger.